156 related articles for article (PubMed ID: 4038578)
1. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
Rodriguez JR; Ramirez-Ronda CH
Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
Rodríguez JR; Ramírez-Ronda CH; Nevárez M
Antimicrob Agents Chemother; 1985 Feb; 27(2):246-51. PubMed ID: 4039118
[TBL] [Abstract][Full Text] [Related]
3. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
4. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
5. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
Nolen TM; Phillips HL; Hall HJ
Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
Pedretti G; Magnani G
G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
[No Abstract] [Full Text] [Related]
8. The place of tobramycin in lower respiratory tract infections (LRTI).
Gialdroni Grassi G
J Chemother; 1995 Aug; 7(4):344-54. PubMed ID: 8568545
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam plus clindamycin as therapy for pelvic infections in women.
Pastorek JG; Cole C; Aldridge KE; Crapanzano JC
Am J Med; 1985 Feb; 78(2A):47-50. PubMed ID: 4038579
[TBL] [Abstract][Full Text] [Related]
10. Comparative clinical efficacy and safety of netilmicin and tobramycin in children with serious gram-negative infections.
Weippl G
Clin Ther; 1983; 5(4):342-7. PubMed ID: 6347380
[TBL] [Abstract][Full Text] [Related]
11. Aztreonam therapy for gram-negative pneumonia.
Greenberg RN; Reilly PM; Luppen KL; Bollinger M; McMillian R
Am J Med; 1985 Feb; 78(2A):31-3. PubMed ID: 3918444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections.
Chaudhary M; Shrivastava SM; Sehgal R
Curr Clin Pharmacol; 2009 Jan; 4(1):62-6. PubMed ID: 19149503
[TBL] [Abstract][Full Text] [Related]
13. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
Birolini D; Moraes MF; de Souza OS
Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of tobramycin in respiratory and systemic infections in immunodepressed and normal patients.
Altucci P; Abbate GF; Alagia I; Leonessa V
J Infect Dis; 1976 Aug; 134 Suppl():S182-6. PubMed ID: 972280
[TBL] [Abstract][Full Text] [Related]
16. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
[TBL] [Abstract][Full Text] [Related]
17. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
19. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
Abbate GF; Alagia I; Gattoni A; Leonessa V; Manguso L; Altucci P
G Ital Chemioter; 1977; 24(1-2):33-7. PubMed ID: 615760
[No Abstract] [Full Text] [Related]
20. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
Henry SA
Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]